本文作者曾报道,癌性腹膜炎患者腹水中的淋巴细胞在IL-2存在下培养,可诱导出活化的杀伤细胞—LAK细胞。此细胞在体外对分离的新鲜肿瘤细胞具有杀伤活性。此次,作者报告了对癌性腹膜炎患者应用腹腔内投与LAK细胞的继承性免疫疗法的效果。观察对象为4名癌性腹膜炎患者(男1名、女3名),其原发癌为胃癌(3名)和胆囊癌(1名)。取患者腹水1000～200ml,400g离心 The authors have reported that lymphocytes in the ascitic fluid of patients with cancerous peritonitis are cultured in the presence of IL-2 to induce activated killer cells, LAK cells. This cell has killing activity on isolated fresh tumor cells in vitro. This time, the authors reported the effect of inherited immunotherapy with intraperitoneal administration of LAK cells to patients with cancerous peritonitis. The observed subjects were 4 patients with cancerous peritonitis (1 male and 3 female). The primary cancers were gastric cancer (3) and gallbladder carcinoma (1). Take ascites 1000 ~ 200ml, 400g centrifuge